New data on inflammatory bowel disease treatment with topical steroids

Research and Clinical Forums

Volumn 20, Issue 1, 1998, Pages 179-188

  Lofberg R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; EUDRAGIT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; STEROID;

CONFERENCE PAPER; CROHN DISEASE; ENTERITIS; ORAL DRUG ADMINISTRATION; RECTAL DRUG ADMINISTRATION; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION; ULCERATIVE COLITIS;

EID: 0031910798     PISSN: 01433083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. BRATTSAND, R. Concepts of topical steroid therapy. Res. Clin. For., 1996; 18: 57-65.
2. LÖFBERG, R. New steroids for inflammatory bowel disease. Inflamm. Bowel. Dis., 1995; 1: 135-141.
3. RUTGEERTS, P. Topical glucocorticoids for the treatment of inflammatory bowel disease. Res. Clin. For., 1995; 17: 143-149.
4. BANSKY, G., BUHLER, H., STAMM, B., HÄCKI, W.H. and BUCHMANN, P. Treatment of distal ulcerative colitis with beclomethasone enemas: High therapeutic efficacy without endocrine side effects. Dis. Colon Rectum, 1987; 30: 288-292.
5. MULDER, C.J.J., FOCKENS, P., MEIJER, J.W.R., VAN DER HEIDE, H., WILTINK, E.H.H. and TYTGAT, G.N.J. Beclomethasone diproprionate (3mg) versus 5-aminosalicylic acid (2g) versus the combination of both (3mg/2g) as retention enemas in active ulcerative proctitis. Eur. J. Gastroenterol. Hepatol., 1996; 8: 549-553.
6. LÖFBERG, R. Combination therapy in active distal ulcerative colitis and proctitis - more studies are warranted. Eur. J. Gastroenterol. Hepatol., 1996; 8: 541-542.
7. THE DANISH BUDESONIDE STUDY GROUP. Budesonide enema in distal ulcerative colitis. A randomised dose-response trial with prednisolone enema as positive control. Scand. J. Gastroenterol., 1991; 26: 1225-1230.
8. DANIELSSON, Å., LÖFBERG, R., PERSSON, T., SALDE, L., SCHIÖLER, R., SUHR, O. and WILLÉN, R. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand. J. Gastroenterol., 1992; 27: 9-12.
9. LÖFBERG, R., ØSTERGAARD-THOMSEN, O., LANGHOLZ, E., SCHIÖLER, R., DANIELSSON, Å., SUHR, O., GRAFFNER, H., PÅHLMAN, L., MARZAN, P., MOELLER-PEDERSEN, J.F., HALVORSEN, L., HOVENAK, L., WILLÉN, R. and PERSSON, T. A comparative study of budesonide versus prednisolone retention enema in active distal ulcerative colitis. A Scandinavian multicenter study. Aliment. Pharmacol. Ther., 1994; 8: 623-629.
10. BIANCHI PORRO, G., PRANTERA, C., CAMPIERI, M., PETRILLO, M., CAMPANINI, M.C., GIOCHETTI, P., GRANDINETTI, G., MANGIAROTTI, R., BRUNETTI, G. and RANZI, T. Comparative trial of methylprednisolone and budesonide enema in active distal ulcerative colitis. Eur. J. Gastroenterol. Hepatol., 1994; 6: 125-130.
11. TARPILA, S., TURUNEN, U., SEPPÄLÄ, K., AUKEE, S., PIKKARAINEN, P., ELOMAA, I., KARVONEN, A.L., KÄÄRIÄINEN, I., SIPPONEN, P., TOIVANEN, E., HEIKUS, B., NURMISS, H., TUNTURI-HIHNNALA, H., BURNHAM, W.R., COWAN, R.E., HINE, K.R., PERSSON, T. and SALDE, L. Budesonide enema in active haemorrhagic proctitis - a controlled trial against hydrocortisone foam enema. Aliment. Pharmacol. Ther., 1994; 8: 591-595.
12. BAYLESS, T., SNINSKY, C. and THE US BUDESONIDE ENEMA STUDY GROUP. Budesonide enema is an effective alternative to hydrocortisone enema in active distal ulcerative colitis. Gastroenterology, 1995; 108: A778.
13. HANAUER, S., ROBINSON, M. and THE US BUDESONIDE STUDY GROUP. Dose ranging study of budesonide enema in active distal ulcerative colitis. Gastroenterology, 1995; 108: A832.
14. LINDGREN, S., SUHR, O., PERSSON, T. and PANTZAR, N. Treatment of active distal ulcerative colitis (UC) and maintenance of remission with Entocort® enema - a randomised controlled dosage study. Gut, 1997; 41: (abstract).
15. LEMANN, M., GALIAN, A., RUTGEERTS, P., VAN HEUVERZWIJN, R., CORTOT, A., VITEAU, J.M., ELEWAUT, A., BELAICHE, J., FROGUEL, E. and MODIGLIANI, R. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment. Pharmacol. Ther., 1995; 9: 557-562.
16. LÖFBERG, R. Oral formulation of budesonide for IBD. Res. Clin. Forum, 1993; 15: 91-96.
17. GREENBERG, G., FEAGAN, B., MARTIN, F., SUTHERLAND, L.R., THOMSON, A.B.R., WILLIAMS, C.N., NILSSON, L.G., PERSSON, T. and THE GLOBAL BUDESONIDE STUDY GROUP. Oral budesonide for the treatment of active Crohn's disease. N. Engl. J. Med., 1994; 331: 836-841.
18. RUTGEERTS, P., LÖFBERG, R., MALCHOW, H., LAMERS, C., OLAISON, G., JEWELL, D., DANIELSSON, Å., GOEBELL, H., THOMSEN, O.O. and LORENZ-MEYER, H. A comparison of budesonide with prednisolone for active Crohn's disease. N. Engl. J. Med., 1994; 331: 842-845.
19. CAMPIERI, M., FERGUSON, A., DOE, W., PERSSON, T., NILSSON, L.G. and THE GLOBAL BUDESONIDE STUDY GROUP. Oral budesonide is as effective as prednisolone in active Crohn's disease. Gut, 1997; 41: 209-214.
20. THOMSEN, O.O., CORTOT, A., JEWELL, D.P., WRIGHT, J.P., WINTER, T., VELOSO, F.T., VATN, M., PERSSON, T., NYLANDER, I. and THE INTERNATIONAL BUDESONIDE-MESALAZINE STUDY GROUP. Budesonide CIR is more effective than mesalazine in active Crohn's disease. A 16 week, international, randomised, double blind, multicenter trial. Gastroenterology, 1997; 112: A1104.
21. MOELLMANN, H.W., HOCHHAUS, G., TROMM, A., MOELLMANN, A., DERENDORF, H., BARTH, J., FROELICH, P., ECKER, K.W. and LINDERMANN, A. Pharmacokinetics and evaluation of systemic side effects of budesonide after oral administration of modified release capsules in healthy volunteers and patients with Crohn's disease. Gastroenterology, 1996; 110: A972.
22. GROSS, V., ANDUS, T., CAESAR, I., BISCHOFF, S.C., TROMM, A., SCHULZ, H.J., BÄR, U., WEBER, A., GIEREND, M., EWE, K., SCHÖLMERICH, J. and THE GERMAN/AUSTRIAN BUDESONIDE STUDY GROUP. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. Eur. J. Gastroenterol. Hepatol., 1996; 8: 905-909.
23. GROSS, V., CAESAR, I., ANDUS, T., VOGELSANG, H., ADLER, G., MALCHOW, H., WEBER, G., M, SCHÖLMERICH, J. and and THE GERMAN/AUSTRIAN BUDESONIDE STUDY GROUP. Dose-finding study with oral budesonide in patients with active Crohn's ileocolitis. Gastroenterology, 1997; 112: A986.
24. GROSS, V., CAESAR, I., ANDUS, T., VOGELSANG, H., ADLER, G., MALCHOW, H., WEBER, A., GIEREND, M., SCHÖLMERICH, J. and THE GERMAN/AUSTRIAN BUDESONIDE STUDY GROUP. Replacement of systemic steroids by oral budesonide in patients with post-active or chronic Crohn's ileocolitis - a dose-finding study. Gastroenterology, 1997; 112: A987.
25. FEAGAN, B., GREENBERG, G., LÖFBERG, R., FERGUSON, A. and PERSSON, T. Budesonide controlled ileal release prolongs remission in Crohn's disease. A pooled analysis. Gastroenterology, 1997; 112: A970.
26. LÖFBERG, R., RUTGEERTS, P., MALCHOW, H., LAMERS, C., OLAISON, G., JEWELL, D., OSTERGAARD-THOMSEN, O., LORENZ-MEYER, H., GOEBELL, H., HODGSON, H., PERSSON, T. and SEIDEGARD, C. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut, 1996; 39: 82-86.
27. GREENBERG, G., FEAGAN, B., MARTIN, F., SUTHERLAND, L.R., THOMSON, A.B.R., WILLIAMS, C.N., NILSSON, L.G., PERSON, T. and THE CANADIAN INFLAMMATORY BOWEL DISEASE STUDY GROUP. Oral budesonide as maintenance treatment for Crohn's disease: A placebo controlled dose-ranging study. Gastroenterology, 1996; 110: 45-51.
28. GROSS, A., ANDUS, T., ECKER, K.W., RAEDLER, A., LOESCHKE, K., WEBER, A., GIEREND, M., EWE, K. and SCHÖLMERICH, J. Oral pH-modified release budesonide for maintenance of steroid induced remission in Crohn's disease - An interim analysis. Gastroenterology, 1995; 108: A828.
29. HELLERS, G., LÖFBERG, R., RUTGEERTS, P., MALCHOW, H., PRANTERA, C., JEWELL, D.P. CORTOT, A., PEÑA, A.S., PALLONE, F., LEIJONMARCK, C.E., GAD, A., NILSSON, L.G. and PERSSON, T. Oral budesonide for prevention of recurrence following ileocecal resection of Crohn's disease. A one year placebo-controlled study. Gastroenterology, 1996; 110: A923.
30. RAEDLER, A., PETERS, I. and SCHREIBER, S. Treatment with azathioptine and budesonide prevents recurrence of ileocolonic stenoses after endoscopic dilation in Crohn's disease. Gastroenterology, 1997; 112: A1067.
31. LÖFBERG, R., DANIELSSON, Å., SUHR, O., NILSSON, Å., SCHIÖLER, R., NYBERG, A., HULTCRANTZ, R., KOLLBERG, B., GILLBERG, R., WILLÉN, R., PERSSON, T. and SALDE, L. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology, 1996; 110: 1713-1718.
32. CUI, N., FRIEND, D.R. and FEDORAK, R.N. A budesonide prodrug accelerates treatment of colitis in rats. Gut, 1994; 35: 1439-1446.